Biolife Solutions (BLFS) Current Deferred Revenue (2010 - 2023)
Biolife Solutions (BLFS) reported Current Deferred Revenue of $422000.0 for Q1 2023, down 52.85% year-over-year from $895000.0 in Q1 2022, and down 22.99% quarter-over-quarter from $548000.0 in Q4 2022.
Biolife Solutions (BLFS) Current Deferred Revenue (2010 - 2023) Analysis & Trends
Biolife Solutions (BLFS) has 14 years of Current Deferred Revenue data on file, last reported at $422000.0 in Q1 2023.
- Current Deferred Revenue for Q1 2023 came in at $422000.0, down 52.85% year-over-year; the trailing twelve-month figure through Mar 2023 was $422000.0 (down 52.85% YoY), and the FY2022 annual result was $548000.0, down 32.68% from the prior year.
- Current Deferred Revenue fell to $422000.0 in Q1 2023 per BLFS's latest filing, from $548000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $944000.0 in Q2 2021 and troughed at $324000.0 in Q4 2019.
- A 5-year average of $646363.6 and a median of $662000.0 in 2021 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2020 and 2022: Current Deferred Revenue soared 187.35% in 2020, then tumbled 54.34% in 2022.
- A 5-year view of Current Deferred Revenue shows it stood at $324000.0 in 2019, then soared by 187.35% to $931000.0 in 2020, then dropped by 12.57% to $814000.0 in 2021, then slumped by 32.68% to $548000.0 in 2022, then dropped by 22.99% to $422000.0 in 2023.
- Business Quant data shows BLFS's Current Deferred Revenue at $422000.0 in Q1 2023, $548000.0 in Q4 2022, and $429000.0 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Biolife Solutions | 1.27 Bn | 1.19 Bn | 17.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 422,000.00 |
| Dec 31, 2022 | 548,000.00 |
| Sep 30, 2022 | 429,000.00 |
| Jun 30, 2022 | 431,000.00 |
| Mar 31, 2022 | 895,000.00 |
| Dec 31, 2021 | 814,000.00 |
| Sep 30, 2021 | 710,000.00 |
| Jun 30, 2021 | 944,000.00 |
| Mar 31, 2021 | 662,000.00 |
| Dec 31, 2020 | 931,000.00 |
| Dec 31, 2019 | 324,000.00 |
| Dec 31, 2018 | 130,000.00 |
| Sep 30, 2018 | 130,216.00 |
| Jun 30, 2018 | 130,216.00 |
| Dec 31, 2017 | 130,000.00 |
| Sep 30, 2017 | 130,216.00 |
| Jun 30, 2017 | 130,216.00 |
| Mar 31, 2017 | 130,216.00 |
| Dec 31, 2016 | 130,216.00 |
| Sep 30, 2016 | 130,216.00 |